R01 GM061753-09/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2010	2
2012	1
2025	0

Page 1

Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.

Abouraya M, Sacco JC, Hayes K, Thomas S, Kitchens CS, Trepanier LA. Abouraya M, et al. J Clin Pharmacol. 2012 Feb;52(2):272-8. doi: 10.1177/0091270010393343. J Clin Pharmacol. 2012. PMID: 21422237 Free PMC article. No abstract available.

Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.

Sacco JC, Trepanier LA. Sacco JC, et al. Pharmacogenet Genomics. 2010 Jan;20(1):26-37. doi: 10.1097/FPC.0b013e3283343296. Pharmacogenet Genomics. 2010. PMID: 19997042 Free PMC article.

Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.

Bhusari S, Abouraya M, Padilla ML, Pinkerton ME, Drescher NJ, Sacco JC, Trepanier LA. Bhusari S, et al. Arch Toxicol. 2010 Aug;84(8):597-607. doi: 10.1007/s00204-010-0530-z. Epub 2010 Mar 11. Arch Toxicol. 2010. PMID: 20221587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year